Long awaited launch of Apomorphine has finally ended. Apomorphine, is expected to provide quick and effective relief to patients suffering from Parkinson’s disease, thereby improving their quality of life.
Currently, patients suffering from Parkinson’s can either opt for oral treatment in the early stages of the disease or choose the more expensive option of deep brain stimulation (DBS) surgery which involves stimulating the brain by placing electrodes through small holes inside the skull, in the advanced stages. However, with the launch of Apomorphine, in the form of injections and infusion pumps, patients will be able opt for oral medication with proven efficacy, at a reasonable cost.
In the case of Parkinson’s patients, the supply of dopamine gets depleted. To keep it under check, the Continuous Dopaminergic Therapy by Apomorphine injections/infusions, which supplies dopamine to the body on a regular and consistent basis thereby negating the fluctuations associated with medications, will be made available.